Holen Sie sich die Stockscreener-App
30.77
11.45%
-4.355
Schlusskurs vom Vortag:
$35.12
Offen:
$31.93
24-Stunden-Volumen:
84,437
Relative Volume:
1.44
Marktkapitalisierung:
$1.48B
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-27.55M
KGV:
-53.80
EPS:
-0.5718
Netto-Cashflow:
$-41.40M
1W Leistung:
-6.07%
1M Leistung:
+0.19%
6M Leistung:
+60.89%
1J Leistung:
+830.86%
1-Tages-Spanne:
$30.60
$32.05
1-Wochen-Bereich:
$30.62
$35.94
52-Wochen-Spanne:
$3.26
$41.89
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
30.60 | 1.70B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
426.10 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
708.96 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
800.36 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.58 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.06 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-06 | Eingeleitet | TD Cowen | Buy |
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - ChartMill
Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
Nanobiotix (NASDAQ:NBTX) Shares Gap UpShould You Buy? - MarketBeat
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Trading Up 3.3% – Time to Buy? - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.3%Time to Buy? - MarketBeat
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5%What's Next? - MarketBeat
Preferred dividends of Nanobiotix SA Sponsored ADR – LS:A2QKZM - TradingView
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives $11.00 Consensus Price Target from Analysts - Defense World
Leerink Partnrs Decreases Earnings Estimates for Nanobiotix - Defense World
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
2.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):